{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:54:38Z","timestamp":1790758478220,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.thromres.2023.10.017","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:29:55Z","timestamp":1699428595000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study"],"prefix":"10.1016","volume":"232","author":[{"given":"Fanny","family":"Bajolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Derridj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lasne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.thromres.2023.10.017_bb0010","doi-asserted-by":"crossref","first-page":"344S","DOI":"10.1378\/chest.119.1_suppl.344S","article-title":"Antithrombotic therapy in children","volume":"119","author":"Monagle","year":"2001","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2023.10.017_bb0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1160\/TH10-09-0608","article-title":"Warfarin treatment outcomes in children monitored at home with a point-of-care device","volume":"105","author":"Biss","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.thromres.2023.10.017_bb0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V118.21.1243.1243","article-title":"The VKORC1 and CYP2C9 genotypes significantly affect vitamin K antagonist dosing only in patients aged 20 years or older","volume":"118","author":"Nowak-Gottl","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2023.10.017_bb0025","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","article-title":"Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients","volume":"94","author":"Streif","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2023.10.017_bb0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood-2011-07-365502","article-title":"Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement","volume":"119","author":"Moreau","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0035","first-page":"710","article-title":"Home point-of-care international normalised ratio monitoring sustained by a non-selective educational program in children","volume":"108","author":"Bajolle","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.thromres.2011.04.020","article-title":"Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit","volume":"128","author":"Wong","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.017_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2017.04.051","article-title":"Safety and efficacy of warfarin therapy in Kawasaki disease","volume":"189","author":"Baker","year":"2017","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002460010078","article-title":"Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting","volume":"21","author":"Marzinotto","year":"2000","journal-title":"Pediatr. Cardiol."},{"issue":"2\u20133","key":"10.1016\/j.thromres.2023.10.017_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-3848(03)00059-8","article-title":"An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.017_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: a review","volume":"16","author":"Harter","year":"2015","journal-title":"West. J. Emerg. Med."},{"issue":"17","key":"10.1016\/j.thromres.2023.10.017_bb0065","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2023.10.017_bb0070","first-page":"559","article-title":"Mechanical valve replacement of the systemic atrioventricular valve in children","volume":"52","author":"Reiss","year":"2006","journal-title":"ASAIO J. Am. Soc. Artif. Intern. Organs 1992"},{"issue":"3","key":"10.1016\/j.thromres.2023.10.017_bb0075","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.thromres.2010.06.017","article-title":"French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)","volume":"126","author":"Pernod","year":"2010","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.017_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.017_bb0085","first-page":"1087","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.017_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12807","article-title":"Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH","volume":"13","author":"Male","year":"2015","journal-title":"J. Thromb. Haemost. JTH"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.017_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1538-7836.2010.04095.x","article-title":"Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment","volume":"9","author":"Watzka","year":"2011","journal-title":"J. Thromb. Haemost. JTH"},{"issue":"5","key":"10.1016\/j.thromres.2023.10.017_bb0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.thromres.2015.08.026","article-title":"EMPoWARed: Edmonton pediatric warfarin self-management study","volume":"136","author":"Bauman","year":"2015","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.017_bb0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.thromres.2008.07.012","article-title":"KIDCLOT: the importance of validated educational intervention for optimal long term warfarin management in children","volume":"123","author":"Bauman","year":"2009","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.017_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2004.03.018","article-title":"Anticoagulation clinics for children achieve improved warfarin management","volume":"114","author":"Newall","year":"2004","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.017_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1051\/ject\/201042009","article-title":"Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery","volume":"42","author":"Gruenwald","year":"2010","journal-title":"J. Extra Corpor. Technol."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/2150135112460866","article-title":"Bleeding and thrombotic emergencies in pediatric cardiac intensive care: unchecked balances","volume":"3","author":"Giglia","year":"2012","journal-title":"World J. Pediatr. Congenit. Heart Surg."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.017_bb0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.121.1.19","article-title":"Clinical observations with the amiodarone\/warfarin interaction: dosing relationships with long-term therapy","volume":"121","author":"Sanoski","year":"2002","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2023.10.017_bb0130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jtcvs.2003.12.013","article-title":"Prosthetic valve thrombosis: twenty-year experience at the Montreal heart institute","volume":"127","author":"D\u00fcrrleman","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0135","first-page":"570","article-title":"Enhanced thrombin regulation during warfarin therapy in children compared to adults","volume":"80","author":"Massicotte","year":"1998","journal-title":"Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.thromres.2023.10.017_bb0140","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood","volume":"54","author":"Gordon","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjcard.2014.11.024","article-title":"Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood","volume":"115","author":"Rizk","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.017_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2013.10.025","article-title":"A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease","volume":"167","author":"Tsuda","year":"2014","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.thromres.2023.10.017_bb0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MBC.0b013e32833d6ec2","article-title":"Management of myocardial infarction in children with Kawasaki disease","volume":"21","author":"Paredes","year":"2010","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.017_bb0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10237-014-0570-z","article-title":"Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease","volume":"13","author":"Sengupta","year":"2014","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.thromres.2023.10.017_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2020.07.022","article-title":"Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease","volume":"321","author":"Low","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.017_bb0170","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/j.ijcard.2013.07.151","article-title":"Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis","volume":"168","author":"Yang","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.017_bb0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41397-019-0117-x","article-title":"CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis","volume":"20","author":"Takeuchi","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.thromres.2023.10.017_bb0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2019.08.002","article-title":"A multi-national trial of a direct oral anticoagulant in children with cardiac disease: design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study","volume":"217","author":"Payne","year":"2019","journal-title":"Am. Heart J."},{"issue":"24","key":"10.1016\/j.thromres.2023.10.017_bb0185","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.thromres.2023.10.017_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.017_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100140","article-title":"What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?","volume":"7","author":"Betensky","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:11Z","timestamp":1758736331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482300302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S004938482300302X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}